等待开盘 10-17 09:30:00 美东时间
0.000
0.00%
Gain Therapeutics, Inc. will participate in the 2026 Maxim Growth Summit from October 12-14 in New York City. The company will meet with institutional investors and engage with Maxim research analysts. Gain’s lead drug candidate, rexaceract, is in a Phase 1b trial for Parkinson’s disease and has potential for Gaucher’s disease, dementia with Lewy bodies, and Alzheimer’s disease. The company uses its Magellan™ platform to develop novel allosteric ...
10-08 11:00
Gain Therapeutics announced a poster presentation at the International Congress of Parkinson’s Disease and Movement Disorders in Seoul, detailing long-term open-label data on its GCase modulator, Rexaceract (GT-02287), for Parkinson’s disease treatment. Rexaceract, an orally administered small molecule, targets GBA1 mutations and age-related stress, restoring GCase function and reducing neurodegenerative markers. The Phase 1 study showed favorabl...
09-29 21:50
Magellan Financial Group Ltd ( ($AU:MFG) ) just unveiled an announcement. Magel...
09-23 15:07
Magellan Financial Group Ltd ( ($AU:MFG) ) just unveiled an update. Magellan Fi...
09-22 07:52
The latest update is out from Magellanic Cloud Ltd. ( ($IN:MCLOUD) ). Magellani...
09-21 13:23
Fidelity Magellan ETF (FMAG) declares $0.001/share quarterly dividend. Payable Sept. 22; for shareholders of record Sept. 18; ex-div Sept. 18. See FMAG Dividend Scorecard, Yield Chart, & Dividend Grow...
09-18 17:27
Gain Therapeutics, Inc. announced that its CEO, Gene Mack, will participate in the ROTH Healthcare Opportunities Conference on September 29, 2026, discussing "Frontiers in Neuroscience." The company is advancing its lead drug candidate, rexaceract, for Parkinson's disease and other conditions, using its Magellan platform to develop innovative therapies.
09-17 11:00
Gain Therapeutics, Inc. announced that its President and CEO, Gene Mack, will participate in one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference in New York City on September 14-16, 2026. An on-demand company presentation will be available starting September 11, 2026, at 7:00 a.m. ET, accessible via the provided links. Gain Therapeutics is a clinical-stage biotechnology company focused on developing next-generation...
08-25 11:00
Magellanic Cloud Ltd. ( ($IN:MCLOUD) ) just unveiled an update. Provigil Survei...
08-18 13:24
PodcastOne (PODC) 2027财年第一季度业绩说明会:营收创下1610万美元的纪录,调整后EBITDA达160万美元,持有700万美元现金且无债务,并实现视频驱动的增长。
08-14 08:35